Abstract:Background: Biological dressings with non-transfusion blood components are among the treatments available for pressure ulcers (PUs). Biological dressings contain active concentrated pro-regenerative molecules that can modify and switch off local inflammatory pathways. This re-establishes the physiological homing, which results in healing. In our study, we used a biological component obtained by ultrafiltration of plasma-platelet concentrate: protein-enriched filtered platelet-rich plasma (PEF PRP ) with a higher platelet and higher plasma protein concentration. We tested whether treatment with PEF PRP could improve healing in advanced-stage pressure ulcers with a large surface area. All the patients in this study had a surgical indication but were not able to undergo surgery for various reasons. Materials and methods: Ten patients with severe neurological disability and advanced-stage sacral pressure ulcers were treated with allogenic PEF PRP . The mean lesion surface area at T0 was 13.4 cm 2 ( ± 9.8 SD). PEF PRP was derived from allogenic plasma-platelet apheresis that had been pre-ultrafiltered with a ProSmartTM filter (Medica, Italy) to obtain a concentration after filtration of the plasma protein (12–16 g/dL) and platelet (1–1.2 x 10 6 microL). Results and Conclusion: All cases showed a reduction in the surface area of the pressure ulcer and in the Pressure Ulcer Scale for Healing (PUSH) score. The mean reduction values at week 6 were as follows: −52% for surface area and −21% for PUSH. Rapid wound healing is fundamental to avoid infections and improve patients' quality of life. This blood component builds new tissue by creating a new extracellular matrix. This, in turn, promotes rapid restoration of the three-dimensional structure of the tissue necessary for healing deeper wounds. PEF PRP shrinks the PU and improves its morphological features (reducing undermining and boosting granulation tissue). PEF PRP also promotes tissue restoration, obtaining an optimal scar. It is a safe and feasible treatment, and these preliminary results support the use of PEF PRP in the treatment of pressure ulcers. PEF PRP dressings could be integrated in the standard treatment of advanced-stage PU.

Successful healing of non-healing surgical wound based on the release of platelet-derived growth factors from single donor allogeneic platelet-RICH plasma with one freeze-thaw cycle: a case report after a 1-year follow-up

Effects of plasma rich in growth factors on wound healing in patients with venous ulcers

Allogeneic Platelet-Rich Plasma: Is It Safe and Effective for Wound Repair?

Allogeneic Platelet Gel Therapy for Refractory Abdominal Wound Healing: A Preliminary Study

Biological approach for the management of non-healing diabetic foot ulcers

Platelet-Rich Plasma (PRP) Promotes Fetal Mesenchymal Stem/Stromal Cell Migration and Wound Healing Process

Platelet-Rich Plasma: Optimal Use in Surgical Wounds

Platelets in wound healing and regenerative medicine

Platelet rich plasma hydrogels promote in vitro and in vivo angiogenic potential of adipose-derived stem cells

Treatment of severe pressure ulcers with protein-enriched filtered platelet-rich plasma (PEFPRP): a possible management

A new simplified technique for producing platelet-rich plasma: a short technical note

Platelet rich plasma-derived microvesicles increased in vitro wound healing

Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series

Efficacy of platelet-rich plasma in alleviating split skin graft morbidities

Microvascular fragment-loaded platelet-rich plasma dressing promotes cutaneous wound healing

Allogeneic platelet‐rich plasma (PRP) is superior to platelets or plasma alone in stimulating fibroblast proliferation and migration, angiogenesis, and chemotaxis as relevant processes for wound healing

Wound Healing: In Vitro and In Vivo Evaluation of a Bio-Functionalized Scaffold Based on Hyaluronic Acid and Platelet-Rich Plasma in Chronic Ulcers

Assessment of the quality of the healing process in experimentally induced skin lesions treated with autologous platelet concentrate associated or unassociated with allogeneic mesenchymal stem cells: preliminary results in a large animal model

Effectiveness of Platelet-Rich Plasma and Hyaluronic Acid for the Treatment and Care of Pressure Ulcers

The Benefits of Using Platelet-rich Plasma with Dermal Substitutes for Extremity Posttraumatic Skin Defects: A Short-term Outcome

The Role of Platelet-Rich Plasma in Reducing Pain, Pruritus, and Improving Wound Healing of Skin Graft Donor Site